Accepted Articles                   Back to the articles list | Back to browse issues page

XML Print

Antihistamines in Pregnancy: A Letter to Editor
Javad Ghaffari
Department of Paediatrics, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran. , javadneg@yahoo.com
Abstract:   (127 Views)
Allergic disorders are increasing prevalence from decades. Often of allergic diseases such as chronic urticaria in some aspects of quality of life of patients affected. Outdoor and indoor allergens can cause   aggravation of symptoms in allergic patients.
H1-antihistamines have been available for decades and those are over-the-counter drugs. The first generation H1-antihistamines have anticholinergic and sedative effects. Basically, their use (H1 blockers) for the routine management of allergic diseases is not recommended.  Second generation H1-antihistamines (bilastine, cetirizine, desloratadine, ebastine, fexofenadine, levocetirizine, loratadine, and rupatadine) have minimally or non-sedating and free of anticholinergic effects. About 10–15% of pregnant women used antihistamine within pregnancy.
Keywords: Antihistamines, Pregnancy
Full-Text [PDF 606 kb]   (53 Downloads)    
Type of Study: Letter to the Editor | Subject: Allergy and Clinical Immunology
Received: 2023/08/22 | Accepted: 2023/01/23 | Published: 2023/01/23
Add your comments about this article : Your username or Email:
CAPTCHA
Send email to the article author

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2023 CC BY-NC 4.0 | Journal of Pediatrics Review

Designed & Developed by : Yektaweb